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Background: Receptor-interacting protein 3 (RIP3), a member of RIP family proteins, has been shown to participate
in programmed necrosis or necroptosis in cell biology studies. Evidence suggests that necroptosis may be a mode
of neuronal death in the retina.
Results: In the present study we determined the expression of RIP3 in normal rat retina and its changes following
acute high intraocular pressure (aHIOP). RIP3 immunoreactivity (IR) was largely present in the inner retinal layers,
localized to subsets of cells expressing neuron-specific nuclear antigen (NeuN), parvalbumin and calbindin in the
ganglion cell layer (GCL) and inner nuclear layer (INL). No double labeling was detected for RIP3 with PKC-α or
rhodopsin. RIP3 immunoreactivity was increased in the GCL at 6 hr and 12 hr, but reduced at 24 hr in the retina,
without apparent alteration in laminar or cellular distribution pattern. Western blot analysis confirmed the above
time-dependent alteration in RIP3 protein expression. RIP3 expressing cells frequently co-localized with propidium
iodide (PI). A few co-localized cells were observed between RIP3 and Bax or cleaved caspase-3 in the GCL in 12 hr
following aHIOP.
Conclusions: The results indicate that RIP3 is expressed differentially in retinal neurons in adult rats, including
subsets of ganglion cells, amacrine and horizontal cells. RIP3 protein levels are elevated rapidly following aHIOP.
RIP3 labeling co-localized with PI, Bax or cleaved caspase-3 among cells in the ganglion cell layer following aHIOP,
which suggest its involvement of RIP3 in neuronal responses to acute ischemic insults.
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Retinal neuronal damage and death are common to a
variety of ophthalmological and neurological conditions,
including retinal injury following acute high intraocular
pressure (aHIOP, a classic ischemia model), retinal pig-
ment epithelium detachment, vascular and age-related
neuronal degenerations [1-3]. Necrosis can be found at
the early stage of aHIOP. Necrosis has been considered
an accidental and uncontrolled form of cell death for a
long time. However, evidence also shows that necrotic
cell death is sometimes controlled as caspase-dependent* Correspondence: xiongkun2001@163.com
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reproduction in any medium, provided the orapoptosis, named it as necroptosis or programmed ne-
crosis. By using the Necrostain-1 (a kind of inhibitor of
necroptosis) and propidium iodide (PI)-staining after re-
tina ischemia, Rosenbaum et al. have found that necrop-
tosis is considered as an important mode of neuronal
cell death during aHIOP, and autophagy deficit may be
involved in this process [4].
Study of cellular necroptosis mechanism has been
linked to RIP (Receptor-interacting protein) family and
its relative molecular pathways. The receptor-interacting
protein 3 (RIP3, also known as RIPK-3) is originally clo-
ned from the human fetal brain and aortic endothelium
and identified as a member of RIP family [5]. Subse-
quently, RIP3 is characterized as a N-terminal Serine/
Threonine kinase capable of perceiving variations inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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survival or death signaling [6]. RIP3 binds to and in-
duces RIP1 phosphorylation, and thus activates the nu-
clear factor-kappa B (NF-κB) [5,7-9]. RIP3 may play a
key role in necroptosis by activating tumor necrosis fac-
tor α (TNF-α) [10-12]. Other data suggest that RIP3
activation may perturb energy metabolism by up-regu-
lating glycogen phosphorylase (PYGL) and glutamate
dehydrogenase, which in turn potentiates superfluous
α-ketoglutarate production and glucose phosphorylation,
and eventually accelerates the Krebs cycle in mitochon-
dria leading to excessive genesis of reactive oxygen spe-
cies (ROS).
Base on the unknown molecular mechanisms of retinal
neuronal necroptosis at the early stage of aHIOP, we
wondered whether RIP3 alteration may be involved in
cell death at the early stage of aHIOP. In the present
study we first characterized the cellular localization of
RIP3 in adult rat retina, and then detected the changes




Twenty-four adult Sprague–Dawley rats weighing 200–
250 grams, available from the animal center of Central
South University, were used in the present study. Rats
were randomly divided into the control group (n=6) and
experimental group (n=18) subjected to induction of
acute high intraocular pressure (aHIOP). All animals
were housed in acrylic box cages with free access to food
and water. Animals were maintained under conditions
of constant temperature (25°C), humidity (50±10%) and
lighting cycle (12:12 hours). All experimental procedures
used in the present study were approved by Ethics Com-
mittee of Xiangya School of Medicine, in accordance
with the NIH guidelines for use and care of laboratory
animals.
Induction of acute high intraocular pressure (aHIOP) and
propidium iodide treatment
The animal model was prepared following the procedure
described by Tong [13]. In brief, Animals were anesthe-
tized with 10% chloral hydrate (0.2 ml/kg). A drop of
chloramphenicol was administered to the conjunctive
sac. A 30-gauge needle connected to the instillation in-
strument filled with normal saline was inserted into the
anterior chamber. The intraocular pressure (IOP) was
elevated to 110 mmHg, maintained for 60 min, and then
gradually lowered to normal. The rats were allowed to
survive for 6, 12 and 24 hrs before terminal use. Thirty
minutes prior to animal perfusion, 5 μl PI (1.0 mg/ml in
DW, Sigma, MO, USA) was administered by intravitreal
injection.Tissue preparation
For anatomical examination, animals were deeply anes-
thetized with 10% Chloral hydrate (Sinopharm Chemical
Reagent Co. Ltd, Shanghai, China) in saline (0.4 ml/kg,
i.p.), followed by trans-cardiac perfusion with saline and
then 4% paraformaldehyde in 0.1 M phosphate buffer
(PB, pH 7.4) at different survival time points. The eye-
balls were enucleated, and the cornea, lens and vitreous
body were removed. The remaining eye cups were post-
fixed in 4% PF overnight, and immersed in ascending
sucrose solutions (15% to 30%) in 0.1 M PB at 4°C
for cryoprotection. The eye cups were embedded in
Optimal-Cutting-Temperature (OCT) medium (Sakura
Finetek, Japan), prepared into 20 μm thick cross-
sections in a Shanton cryostat (Thermo-Fisher Scientific
Inc., CA, USA). Sections were thaw-mounted on posi-
tively charged microslides (Thermo-Fisher Scientific
Inc., CA, USA), allowed to air-dry and then stored at
−20°C before further histological processing. For western
blot analysis, eyeballs were removed immediately from
deeply anesthetized rats after a vascular rinse with cold
saline, and the retinas were dissected out and snap-
frozen on dry-ice and stored at −70°C until tissue
homogenization.
Immunohistochemistry
For immunolabeling with the avidin-biotin complex
(ABC) method, sections were treated in 0.3% H2O2 in
0.01M phosphate buffered saline (PBS, pH 7.3) for 15
minute to inactivate endogenous peroxidase. Non-spe-
cific antibody binding was blocked by a pre-incubation
of sections in 5% normal horse serum (Sigma, MO,
USA) in PBS containing 0.3% Triton X-100 (Fluka, CA,
USA) for 1 hour at room temperature. Sections were
then incubated with a rabbit anti-RIP3 antibody at 4°C
overnight (Table 1), then reacted with biotinylated horse
anti-rabbit IgG (1:400, Vector Laboratories Inc., CA,
USA) for 2 hours at room temperature. After 1 hour in-
cubation with the avidin-biotin complex reagents (1:400,
Vector Laboratories Inc., CA, USA), immunoreaction
product was visualized in PBS containing 0.05% DAB
(Sigma, MO, USA) and 0.03% H2O2. Finally, the sections
were dehydrated, cleared and coverslippered. The spe-
cificity of the RIP3 antibody was evaluated by pre-
absorption and omission of the primary antibody in
immunohistochemistry. Western blot was also used to
confirm the antibody binding product.
For double immunofluorescence of RIP3 co-localiza-
tion in normal retina, sections were pre-incubated for 60
minutes in 5% donkey serum (Sigma, MO, USA) in PBS
containing 0.3% Triton X-100 at room temperature. Sec-
tions were incubated with the rabbit anti-RIP3 antibody
and one of the mouse antibodies to neuronal and glial
markers overnight (listed in Table 1). After several times
Table 1 Primary antibodies used in the present study
Antibody Host Source Dilution
Receptor-interacting protein 3 (RIP3) Rabbit Sigma-Alorich, PRS2283 (1:200)
Receptor-interacting protein 3 (RIP3) Goat Santa Cruz, sc-47364 (1:500)
Calbindin (CB) Mouse Sigma-Alorich, C9848 (1:4000)
CD11b Mouse Abcam, ab78457 (1:500)
Glial fibrillary acidic protein (GFAP) Mouse Abcam, ab10062 (1:1000)
Glutamine synthetase (GS) Mouse Abcam, ab64613 (1:5000)
Neuron-specific nuclear antigen (NeuN) Mouse Abcam, ab104224 (1:1000)
Protein kinase C alpha (PKCα) Mouse Abcam, ab86715 (1:500)
Parvalbumin (PV) Mouse Sigma-Alorich, P3088 (1:4000)
Rhodopsin(Rho) Mouse Sigma-Alorich, R5403 (1:1000)
Synaptophysin(Syn) Mouse Sigma-Alorich, S5768 (1:2000)
β-Tubulin Rabbit Abcam, ab6046 (1:1000)
Cleaved caspase-3 Rabbit Millipore, AB3623 (1:200)
Bax Mouse Sigma-Alorich, B8429 (1:200)
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Cy3-conjugated donkey anti-mouse and anti-rabbit sec-
ondary antibodies at 1:200 (Invitrogen, CA, USA). The
sections were then briefly incubated in Bisbenzimide
(Hoechst 33258, Sigma, MO, USA) at 1:50,000, washed in
PBS and covered with an anti-fading mounting medium
(Abcam, MA, USA) before microscopic examination.
For immunofluorescence of RIP3 and double labeling
of RIP3 with Bax or cleaved caspase-3 following aHIOP,
sections were pre-incubated for 60 minutes in 5% don-
key serum (Sigma, MO, USA) in PBS containing 0.3%
Triton X-100 at room temperature. Sections were in-
cubated with the rabbit anti-RIP3 antibody (for RIP3
expression test) or goat anti-RIP3 and Bax or cleaved
caspase-3 antibodies overnight. After several times rinses
with PBS, sections were reacted with Cy2 and Cy3-
conjugated donkey anti-rabbit/donkey anti-goat/donkey
anti-mouse secondary antibodies at 1:200 (Invitrogen,
CA, USA). The sections were then briefly incubated in
Bisbenzimide, washed in PBS and covered with an anti-
fading mounting medium (Abcam, MA, USA) before
microscopic examination.
For double labeling of PI-labeled cells and RIP3 fol-
lowing aHIOP. 12 hr of PI-pretreated retinal sections
were selected to carry out RIP3 immunofluorescence
staining. The protocol of RIP3 immunofluorescence
staining have illustrated before. Photograph were using a
confocal microscope (Nikon, DIGITAL ECLIPSE C1 plus,
Japan) fitted with excitation/emission filters 568/585
for PI.
Immunoblotting
Retinas were homogenized by sonication on ice in a di-
gestion buffer [150 mM NaCl, 25 mM Tris- HCl (pH7.4), 2 mM EDTA, 1.0% Triton X-100, 1.0% sodium
deoxycholate, 0.1% SDS] containing a cocktail of prote-
ase inhibitors (Sigma, MO, USA). Homogenates were
centrifuged at 10,000×g for 20 min at 4°C. The superna-
tants were collected, and protein concentration deter-
mined by Bicinnchoninic acid (BCA) assay (Pierce, IL,
USA). A total of 100 μg of protein in 62.5 mM Tris load-
ing buffer (pH 6.8, containing 25% glycerol, 2% SDS,
0.01% bromophenol blue and 5% β-mercaptoethanol,
Bio-Rad, CA, USA), was boiled for 10 min, and loaded
in each lane of 4-20% linear gradient Tris–HCl ready gel
(Bio-Rad, CA, USA). The polypeptides were electro-
transferred to Trans-BlotW pure nitrocellulose mem-
brane (Bio-Rad, CA, USA). Non-specific binding was
blocked with PBS containing 5% nonfat milk (Bio-Rad,
CA, USA) and 3% bovine serum albumin (Sigma, MO,
USA). Membranes were incubated with RIP3 or β-tubu-
lin antibodies overnight, and then in HRP-conjugated
secondary antibodies (1:20000, Bio-Rad, CA, USA) for 1
hour. Immunoblotting products were visualized with an
ECL Plus™ Western Blotting Detection kit according to
manufacturer’s instruction (GE Healthcare Life Sci., NJ,
USA), and images captured in a Molecular Dynamics
Phosphor imager (Nucleo Tech Inc., CA, USA). For
RIP3 antibody specific test, nitrocellulose membranes
were blotted for RIP3 with the presence of the immu-
nogenic peptide corresponding to amino acids 473 to
486 of murine RIP3 (US Biological, R2031-74P, at 1:10
dilution).
Imaging and data analysis
Sections were examined on an Olympus (BX53, Tokyo,
Japan) microscope equipped with a digital camera and
imaging system (CellSens Standard, Olympus, Tokyo,
Figure 1 Antibody characterization (A-C) and overall laminar distribution of RIP3 immunolabeling in the adult rat retina (D-F). Panel (A)
shows an immunoblotting test of the antibody, which reveals a single band migrated at 57 kDa, blockable by preincubation of the immunogenic
peptide with primary antibody. Panels (B and C) show that the antibody labeling (B) can also be eliminated by the pre-absorption peptide in
immunofluorescent preparation. Panels (D) and enlargements (E, F) show RIP3 immunolabeling revealed by the avidin-biotin-peroxidase method.
Labeling appears mostly in the inner retinal layers and the pigment epithelium layer (PEL) (D). Many labeled somata are present in the ganglion
cell layer and some also seen in the inner nuclear layer (INL). PL: photoreceptor layer; ONL: outer nuclear layer; OPL: outer plexiform layer; INL:
inner nuclear layer; IPL: inner plexiform layer; NFL, nerve fiber layer. Scale bar=70 μm in B, C and 100 μm in D, 50 μm in E, F.
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focal microscope (Nikon, DIGITAL ECLIPSE C1 plus,
Japan) for RIP3 distribution double immunolabeling and
RIP3 immunofluorescence following aHIOP. For double
labeling of Bax or cleaved caspase-3 with RIP3, the slices
were examined with a confocal microscope (Carl Zeiss,
Axiovert 200M, Germany). In the latter case, immuno-
fluorescence was scanned from 1 μm depth of tissue
(i.e., 5–6 μm below the section surface) around the mid-
dle segment of retina between the optic nerve disk andFigure 2 Confocal double immunofluorescent images showing coloca
calbindin (I-L') in adult rat retina. Hoechst nuclear labeling (blue) shows
indicated. RIP3 immunoreactivity co-localize with NeuN frequently (D) in th
the inner nuclear layer. Scale bar=50 μm in A-L, Bar=25 μm in F’, F”; G’, G”periphery. Semi-quantitative analyses were conducted
using approximately 20 merged images (40×) from 4 ani-
mals (5 sections per animal) to estimate the frequency of
colocalization. Figure panels were assembled using Pho-
toshop CS5 (Adobe Systems Incorporated, CA, USA).
Image J (National Institutes of Health, MD, USA) were
used to analyze the optical density value of the RIP3
bands by western blot. The average values of RIP3 and
β-Tubulin were compared, the average relative value was
obtained. One-way analysis of variance was performedlization of RIP3 with NeuN (A-D), parvalbumin (E-H') and
the laminas of the retina (A, E, I). Framed areas are enlarged as
e ganglion cell layer, and partially with parvalbumin and calbindin in
; H’, H”. Abbreviations are as defined in Figure 1.
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were presented as mean ± SD. A value of p<0.05 was
considered statistically significant.
Results
Overall laminar distribution of RIP3 immunoreactivity in
retina
The RIP3 antibody detected a monoband migrated ap-
proximately at 57 kDa, consistent with the previous re-
ports regarding the molecular weight of the protein [8].
In the presence of the immunogenic peptide, thisFigure 3 Confocal images illustrating double labeling for RIP3 with p
synaptophysin (I-L) in adult rat retina. RIP3 labeling appears not to co-lo
layer, light RIP3 immunofluorescence appears to be interposed with the str
(L). Scale bar=50 μm in A-L. Abbreviations are as defined in Figure 1.immunoblotting band was eliminated (Figure 1A). Simi-
larly, RIP3 immunoreactivity in retinal cross-section
could be abolished by pre-absorption of the primary an-
tibody with the neutralizing peptide (Figure 1B,C), or
omission of the primary or secondary antibody (data not
shown).
Immunohistochemistry using the peroxidase-DAB me-
thod visualized a fairly broad laminar distribution of
RIP3 IR in the retina. Overall, a strong cellular labeling
was notable in the ganglion cell layer (GCL), with some
labeled somata also seen in the inner nuclear layer (INL)rotein kinase C-α (PKCα) (A-D), rhodopsin (E-H) and
calize with PKCα in the inner nuclear layer. In the inner plexiform
ong immunoreactivity for PKCα (D), rhodopsin (H) and synaptophysin
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like labeling was present in the inner plexiform layer
(IPL). Weak labeling was found over the outer plexi-
form layer (OPL) to photoreceptor layer (PL). The pig-
ment epithelium cells exhibited fairly strong labeling
(Figure 1D-F).
Double labeling for RIP3 and neuronal markers in retina
Confocal double immunofluorescence was carried out
to determine RIP expression relative to markers ofFigure 4 Confocal light microscopic images illustrating RIP3 immuno
retina (PKCα). In the ganglion cell layer, RIP3 expressing somata appear to
immunoreactivity for glutamine synthetase (GS) that visualizes Müller cells
and CD11b (J-L) double immunofluorescence, these two glial markers are e
A-L. Abbreviations are as defined in Figure 1.major neuron phenotypes in the retina. In the GCL
(Figure 2A-D), the cellular labeling of RIP3 was found
to be commonly co-localized with NeuN [14]. Prelim-
inary cell count using high magnification (40X) images
revealed that RIP3 labeling was found in approximately
42% of NeuN positive perikarya in the GCL (89/214). In
the INL, RIP3 IR was found to coexist in amacrine-like or
horizontal-like neurons that were immunoreactive either
for parvalbumin (amacrine cell marker) (Figure 2E-H)
or calbindin (horizontal cell marker) (Figure 2I-L)[15],labeling relative to immunolabeling of glial cells in adult rat
be tightly apposed to (or potentially co-localized with
(B-D). A similar pattern is seen between RIP3 and GFAP (F-H) or RIP3
xpressed in astrocyte and microglia in the retina. Scale bar=50 μm in
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spectively. In contract, no co-localization of RIP3 IR was
detected in the INL among neurons expressing PKCα
(Figure 3A-D), a marker for bipolar cells [16]. Further, no
distinct co-localization was found between RIP3 and rhod-
opsin in the photoreceptor cells [14] or their terminals
(Figure 3E-H).
As seen with the peroxidise-DAB preparations
(Figure 1D), weak RIP3 IR appeared in the inner and
outer plexiform layers of the retina in confocal light
microscopy (Figure 3B, F, J). In double immunofluo-
rescence, this terminal-like RIP3 labelling was weaker
relative to synaptophysin immunoreactivity in the IPL
and OPL (Figure 3K). Close examination indicated that
RIP3 and synaptophysin immunoreactivities appeared
to be not co-localized in these two plexiform layers
(Figure 3J-L).
Double labeling for RIP3 and glial markers in retina
In order to further determine whether RIP3 expression
occurred in glial cells in retina, double immunofluores-
cence was performed for RIP3 with glutamine synthetaseFigure 5 Confocal microscopic images illustrating RIP3 expression fol
following aHIOP at different survival time point. In the ganglion cell layer, i
somata in 6 hr and 12 hr groups (B-D). Scale bar=50 μm in A-H, Scale bar=(GS), GFAP, CD11b, markers for Müller cells, astrocytes
and microglia, respectively. RIP3 and GS immunolabeled
elements apposed closely to each other in the GCL
(Figure 4A-D), representing an interposing arrangement
of the ganglion cells and Müller glia [17]. The might
exist infrequent co-localization between the two markers
(Figure 4B-D). GFAP immunoreactive astrocytes were
distributed in nerve fiber layer and ganglion cell layer.
No clear somata co-localization was detectable between
RIP3 and GFAP labeling, although small process-like
element appears to exhibit double labeling (Figure 4E-
H). CD11b immunoreactivities were also largely located
to the inner retina. Double labeling was detectable around
the RIP3 immunoreactive somata or at process-like ele-
ments in the GCL and NFL (Figure 4I-L).
Changes of RIP3 expression following aHIOP
The immunofluorescence staining result showed that
RIP3 was mainly present in ganglion cell layer (GCL),
nerve fiber layer (NFL), inner plexiform layer (IPL) and
inner nuclear layer(INL), but weakly staining occurs in
other layers in retina (Figure 5), meanwhile, no differencelowing aHIOP. The pattern of RIP3 expressing was not changed
ntensity of RIP3 immunoreactivity were appeared to be up-regulate in
25 μm in A-D. Abbreviations are the same as detailed in Figure 1.
Figure 6 Western blot analysis result of RIP3 following aHIOP. The protein level of RIP3 is increased at 6 hr or 12 hr, and tends to be normal
at 24 hr. Panel A: bands of RIP3 and β-tubulin; Panel B: optical density analysis of RIP3; Error bars represent standard deviation, 12hr vs other
groups *p<0.05.
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the normal controls, significantly more distinct and heav-
ier RIP3 immunoreactive showed in aHIOP animal mo-
dels, a strong cellular labeling of RIP3 in 6 hour and 12
hour groups was found, but weakly found in 24 hour
groups.
The western blot results showed that RIP3 was main-
ly exhibited as a single 57 kDa band in all groups
(Figure 6A). The bands in aHIOP groups were appar-
ently thicker and larger than those of normal control
groups. The band in 24 hour groups was thinner and
smaller than those in injury groups and tended to be
normal. β-tubulin was mainly exhibited as a single 54
kDa band respectively in all four groups.Figure 7 Confocal microscopic images illustrating double labeling of
12 hr. The pattern of RIP3 expression appears comparable relative to norm
immunoreactivity appears somewhat up-regulated in neuronal somata, and
panel A-H. Abbreviations are the same as detailed in Figure 1.The optical density measurement and statistical ana-
lysis indicated that aHIOP up-regulated the expression
of RIP3 in the early stage (Figure 6B). The values of
the bands density showed as following: Normal control
(0.52±0.13), 6 hr (0.59±0.24), 12 hr (0.81±0.18) and 24
hr (0.41±0.14). It demonstrated that RIP3 bands density
were increased firstly and then decreased as time extend
within 1day.
Double labeling for RIP3 and PI in retina following aHIOP
at 12 hr
PI-positive cells were largely detected in the ganglion
cell layer (GCL) and inner nuclear layer (INL) in 12 hr
group (Figure 7). PI-stainings were localized in nuclei, asRIP3 and propidium iodide (PI) positive cells following aHIOP at
al controls. In the ganglion cell layer, intensity of RIP3
commonly colocalizes with PI positivity (H). Scale bar=50 μm for
Figure 8 (See legend on next page.)
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(See figure on previous page.)
Figure 8 Confocal microscopic images illustrating double labeling of RIP3 with Bax or cleaved caspase-3 positive cells following aHIOP
at 12 hr. Compared to control group (Panel A-E, Panel K-O), Bax (Panel P-T) and cleaved caspase-3 (Panel F-J) positive cells occur in GCL in 12
hr group. Some Bax or cleaved caspase-3 positive cells show strong RIP3 (arrow head shown). Some strong positive staining of RIP3 did not
presence Bax or cleaved caspase-3 strong expression (arrow shown). Scale bar=20 μm in all panels. Abbreviations are as defined in Figure 1.
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ence of necrosis cells in GCL and INL after 12 hr post-is-
chemia. RIP3 and PI co-localization was found in GCL,
with some PI-positive cells exhibited very strong RIP3
(white arrow show).
Double labeling for RIP3 and Bax or cleaved caspase-3 in
retina following aHIOP at 12 hr
There was no distinct cellular staining of Bax and cleaved
caspase-3 in normal rat retina (see Figure 8). Bax and
cleaved caspase-3 positive cells were detected in GCL in
12 hr group, both of them were localized to nuclei, as con-
firmed with bisbenzimide staining. RIP3 labeling was
found to colocalization with Bax or cleaved caspase-3 in
GCL. Some Bax or cleaved caspase-3 positive cells exhib-
ited strong RIP3 (arrow head shown). However, some
strongly labeled RIP3 cells did not exhibit Bax or cleaved
caspase-3 reactivity (arrow shown).
Discussions
The retina is a part of the central nerve system and con-
tains many types of neurons and glia cells with their
somata and processes arranged in a stratified manner
[18,19]. The retina has been used as an in vivo model for
studying neuron stress and/or death in the central ner-
vous system [13,20-23]. Also, retinal neuronal degener-
ation itself is characterized in many clinical conditions
that can lead to blindness [24]. Understanding the mo-
lecular mechanism underlying cell stress and death in
the retina may help develop therapeutic intervention for
visual impairment. Neuronal death owing to necrosis
and apoptosis may exist in the retina under pathological
conditions [25]. For instance, high intraocular pressure
may cause necrosis and delayed apoptosis in the retina,
as characterized in experimental models [26-28]. More
recently, it is suggested that programmed necrosis, also
called necroptosis, may occur at the early stage of
aHIOP [4]. This lately-recognized type of cell death may
play an important role in neuronal degeneration in the
inner retinal layers, namely the ganglion cell and inner
nuclear layers.
RIP3 is mainly expressed in neurons in the inner layer of
normal rat retina
This present study reveals that RIP3 is constitutively
expressed in the adult rodent retina. The RIP3 IR is de-
tected across most neuronal somata and terminal layers of
the retina, with labeling presented largely in the neuronalcomponents. There exists a differential RIP3 among retina
neurons in normal adult rat retina. Thus, RIP3 IR is fairly
abundant in the NFL and GCL, wherein the labeling is
found largely in the ganglion cells. Some discretely labeled
elements appear to be the glial cells in this inner retinal
location, including Müller cells, astrocytes and microglia,
although it is not certain whether the “co-localized pro-
files” are due to an proximity of the neuron-glia spatial ar-
rangement, e.g., the ganglion cells vs Müller cells in the
GCL. The double labeling data in the present study also
suggests a residential expression of RIP3 in subpopula-
tions of neurons that contain parvalbumin or calbindin.
On the contrary, bipolar cells generally do not appear to
exhibit impressive RIP3 labeling. Moreover, photorecep-
tors appeared to express RIP3 at minimal levels under
normal condition. The weak RIP3 reactivity in plexiform
layers (more noticeable in the IPL) might relate to a den-
dritic labeling because there is no apparent co-localization
of RIP3 and synaptophysin. Overall, the laminar and cellu-
lar RIP3 expression patterns appear to be compatible with
a notion that the up-regulation of this molecule could
occur largely in the inner retinal layers, and may mediate
necroptosis there under certain conditions. It should be
noted that RIP3 expression in the photoreceptor cells is
low under normal condition, although a strong RIP3 ex-
pression exists in the retinal pigment epithelial cells. The
relevance of this distribution pattern at the outer layer of
retina to the reported up-regulation of RIP3 following pig-
ment epithelium detachment remains an interesting issue
to investigate [29]. Finally, we should mention that the
distribution of RIP3 in normal adult retina was conducted
by immunohistochemistry, which has limitations. Our fu-
ture studies, such as in situ hybridization, are warranted
to further understanding of RIP3 expression in the retina.
RIP3 expression is up-regulated in retina ganglion cells at
early stage of aHIOP
Data are considerably limited to date with regard to the
expression of RIP3 in the brain under normal and patho-
logical conditions [7,29]. Nonetheless, recent evidence
suggests that RIP3 may serve an important cellular fac-
tor regulating cellular/neuronal stress and death, pos-
sible by mediating necroptosis. A recent study in the
retina demonstrates an up-regulation of RIP3, up to 10
fold, in an experimental model of retinal detachment,
suggestive of a potential implication for necroptosis
[29]. Interestingly, in a preliminary gene-chip analysis
we noticed an early but marked increase in RIP3 mRNA
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lished data). In the present study, RIP3 protein levels
begin to increase at 6 hr, and reached maximum at 12 hr
(12 hr vs other groups, p<0.05), implicating an involve-
ment of RIP3 modulation at the early stage of aHIOP.
However, currently there is no suitable morphological
marker for necroptosis in vivo [30]. Using PI staining
that labels necrotic cells, the present study show that
RIP3 expressing cells may also PI-positive in GCL at 12
hr following aHIOP. Our double labeling results show
there is small extent of co-localization of RIP3 with
Bax or cleaved caspase-3 in GCL. However, some RIP3
strong expression cells are not exhibit Bax or cleaved
caspase-3 reactivities. This finding suggests that RIP3
regulation may be potentially involved in the process
of neuronal injury or death. Previous studies have repor-
ted that over-expression of RIP3 may induce apoptosis
[5,8,12], our results are consistent with these finding.
However, our results show that not all RIP3-upregulated
cells exhibit co-localization with apoptosis relative pro-
teins (Bax or cleaved caspase-3), which indicated that
some RIP3 over-expression may not induce apoptosis.
Based on the evidence of co-localization between RIP3
strong expression cells and PI-staining (Figure 7), we
speculate that RIP3 up-regulation may participate in
RGCs necroptosis following aHIOP. However, because
there is no specific marker for necroptosis, future studies
are required to determine the precise role of early RIP3-
upregulation in retinal injury and diseases [28,31,32].
Conclusion
This present study demonstrates that RIP3 is expressed
differentially in retinal neurons in adult rats, including
subsets of ganglion cells, amacrine and horizontal cells.
RIP3 expression in RGCs is up-regulated following aHIOP,
suggesting an involvement of RIP3 in neuronal responses
to acute ischemic insults.
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